Go to deals

Healthcare | Private Equity

LDI has sold UltiMed to Levine Leichtman Capital Partners

UltiMed, Inc., a portfolio company of LDI, Ltd., has been sold to an investment vehicle sub-managed by Levine Leichtman Capital Partners, LLC.

UltiMed’s insulin pen needles, syringes and complementary products are critical offerings for diabetes patients who need daily insulin injections and for companion animals who increasingly suffer from this life-threatening disease. UltiMed’s proprietary “dispense and dispose” solutions provide diabetes patients a safe and convenient way to store used sharps following injection.

Levine Leichtman Capital Partners is a private equity and venture capital firm specializing in acquisitions, buyouts, recapitalizations, refinancing, balance sheet restructuring, growth financing, structured equity, distressed debt, leveraged loan and mezzanine investments in the middle market.

LDI, Ltd. is a private equity firm specializing in investing in acquisitions and add-on acquisitions. It is a family office based in Indianapolis, IN, with more than a century of experience funding and operating high-potential, middle-market companies.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to UltiMed, Inc., a portfolio company of LDI, Ltd., in this transaction.

Service

M&A sell-side

Parties

“We selected the team based on their prior experience with UltiMed and their expertise in transactions in the diabetes and animal health sectors. They did an outstanding job of presenting UltiMed’s many strengths and growth opportunities to the market, and their deep relationships with potential acquirors were key to our success. We particularly appreciate the senior team focus they brought to completing this transaction despite the emergence of the COVID-19 pandemic in the midst of this assignment.”

John Martin

VP Corporate Development, LDI, Ltd.

Talk to the deal team

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital

View profile Get in touch

John Dean

Managing Director

Atlanta, United States
Oaklins TM Capital

View profile Get in touch

Steve Hunter

Managing Director

Atlanta, United States
Oaklins TM Capital

View profile Get in touch

James McLaren

Managing Director

New York, United States
Oaklins TM Capital

View profile Get in touch

Related deals

TEAM Safety Services Limited has been acquired by Vadella Group

Private Equity | Business Support Services

TEAM Safety Services Limited has been acquired by Vadella Group

TEAM Safety Services Limited, a leading UK-based health, safety and fire safety consultancy, has been acquired by Vadella Group, a specialist provider of inspection-led compliance services for the built environment.

Learn more

MEDIK Hospital Design Group has been acquired by STERIS

Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more

Sunrise Eggs has been acquired by Agrova International

Private Equity | Agriculture | Food & Beverage

Sunrise Eggs has been acquired by Agrova International

Sunrise Eggs, one of the UK’s best-established independent egg producers and distributors, has joined Agrova International AS, a European poultry and agri-foods group.

Learn more